ℹ️ Skipped - page is already crawled
| Filter | Status | Condition | Details |
|---|---|---|---|
| HTTP status | PASS | download_http_code = 200 | HTTP 200 |
| Age cutoff | PASS | download_stamp > now() - 6 MONTH | 0.5 months ago |
| History drop | PASS | isNull(history_drop_reason) | No drop reason |
| Spam/ban | PASS | fh_dont_index != 1 AND ml_spam_score = 0 | ml_spam_score=0 |
| Canonical | PASS | meta_canonical IS NULL OR = '' OR = src_unparsed | Not set |
| Property | Value |
|---|---|
| URL | https://www.nimh.nih.gov/health/statistics/mental-illness |
| Last Crawled | 2026-04-01 02:46:51 (15 days ago) |
| First Indexed | 2021-05-02 06:25:53 (4 years ago) |
| HTTP Status Code | 200 |
| Meta Title | Mental Illness - National Institute of Mental Health (NIMH) |
| Meta Description | An overview of statistics for mental illnesses. Mental illnesses are common in the United States. One in six U.S. adults lives with a mental illness (43.4 million in 2015). Mental illnesses include many different conditions that vary in degree of severity, ranging from mild to moderate to severe. |
| Meta Canonical | null |
| Boilerpipe Text | Mental illnesses are common in the United States and around the world. It is estimated that more than one in five U.S. adults live with a mental illness (59.3 million in 2022; 23.1% of the U.S. adult population). Mental illnesses include many different conditions that vary in degree of severity, ranging from mild to moderate to severe. Two broad categories can be used to describe these conditions: Any Mental Illness (AMI) and Serious Mental Illness (SMI). AMI encompasses all recognized mental illnesses. SMI is a smaller and more severe subset of AMI. Additional information on mental illnesses can be found on the
NIMH Health Topics Pages
.
Definitions
The data presented here are from theÂ
2022 National Survey on Drug Use and Health (NSDUH)Â
by theÂ
Substance Abuse and Mental Health Services AdministrationÂ
 (SAMHSA). For inclusion in NSDUH prevalence estimates, mental illnesses include those that are diagnosable currently or within the past year; of sufficient duration to meet diagnostic criteria specified within the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV); and, exclude developmental and substance use disorders.
Any Mental Illness
Any mental illness (AMI)
is defined as a mental, behavioral, or emotional disorder. AMI can vary in impact, ranging from no impairment to mild, moderate, and even severe impairment (e.g., individuals with serious mental illness as defined below).
Serious Mental Illness
Serious mental illness (SMI)
is defined as a mental, behavioral, or emotional disorder resulting in serious functional impairment, which substantially interferes with or limits one or more major life activities. The burden of mental illnesses is particularly concentrated among those who experience disability due to SMI.
Prevalence of Any Mental Illness (AMI)
Figure 1 shows the past year prevalence of AMI among U.S. adults.
In 2022, there were an estimated 59.3 million adults aged 18 or older in the United States with AMI. This number represented 23.1%Â of all U.S. adults.
The observed prevalence of AMI was higher among females (26.4%) than males (19.7%).
Young adults aged 18-25 years had the highest prevalence of AMI (36.2%) compared to adults aged 26-49 years (29.4%) and aged 50 and older (13.9%).
The prevalence of AMI was highest among the adults reporting two or more races (35.2%), followed by White adults (24.6%). The prevalence of AMI was lowest among Asian adults (16.8%).
Figure 1
Past Year Prevalence of Any Mental Illness Among U.S. Adults (2022)
Bar chart with 12 bars.
Data Courtesy of SAMHSA
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying Percent. Range: 0 to 40.
End of interactive chart.
Past Year Prevalence of Any Mental Illness Among U.S. Adults (2022)
Demographic
Percent
Overall
23.1
Sex
Female
26.4
Male
19.7
Age
18-25
36.2
26-49
29.4
50+
13.9
Race and Ethnicity
Hispanic or Latino*
21.4
White
24.6
Black or African American
19.7
AI/AN
19,6
Asian
16.8
2 or More
35.2
*Persons of Hispanic origin may be of any race; all other racial/ethnic groups are non-Hispanic. AI/AN = American Indian / Alaskan Native
**Note: Estimates for the Native Hawaiian / Other Pacific Islander group are not reported in the above figure due to low precision of data collection in 2022.
Mental Health Treatment — AMI
Figure 2 presents data on mental health treatment received within the past year by U.S. adults aged 18 or older with any mental illness (AMI). NSDUH defines mental health treatment as having received inpatient treatment/counseling or outpatient treatment/counseling, or having used prescription medication to help with mental health.
In 2022, among the 59.3 million adults with AMI, 30.0 million (50.6%) received mental health treatment in the past year.
More females with AMI (56.9%) received mental health treatment than males with AMI (41.6%).
The percentage of young adults aged 18-25 years with AMI who received mental health treatment (49.1%) was slightly lower than adults with AMI aged 26-49 years (50.0%) and aged 50 and older (52.7%).
Figure 2
Mental Health Treatment Received in Past Year Among U.S. Adults with Any Mental Illness (2022)
Bar chart with 11 bars.
Data Courtesy of SAMHSA
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying Percent. Range: 0 to 60.
End of interactive chart.
Mental Health Treatment Received in Past Year Among U.S. Adults with Any Mental Illness (2022)
Demographic
Percent
Overall
50.6
Sex
Female
56.9
Male
41.6
Age
18-25
49.1
26-49
50.0
50+
52.7
Race and Ethnicity
Hispanic or Latino*
39.6
White
56.1
Black or African American
37.9
Two or More Races
56.0
Asian
36.1
*Persons of Hispanic origin may be of any race; all other racial/ethnic groups are non-Hispanic. Note: Estimates for the Native Hawaiian / Other Pacific Islander group is not reported in the above figure due to low precision of data collection in 2022.
Prevalence of Serious Mental Illness (SMI)
Figure 3 shows the past year prevalence of SMI among U.S. adults.
In 2022, there were an estimated 15.4 million adults aged 18 or older in the United States with SMI. This number represented 6.0% of all U.S. adults.
The observed prevalence of SMI was higher among females (7.1%) than males (4.8%).
Young adults aged 18-25 years had the highest prevalence of SMI (11.6%) compared to adults aged 26-49 years (7.6%) and aged 50 and older (3.0%).
The prevalence of SMI was highest among adults reporting two or more races (11.8%), followed by American Indian / Alaskan Native (AI/AN) adults (7.3%). The prevalence of SMI was lowest among Native Hawaiian / Other Pacific Islander (NH/OPI) adults (3.5%).
Figure 3
Past Year Prevalence of Serious Mental Illness Among U.S. Adults (2022)
Bar chart with 13 bars.
Data Courtesy of SAMHSA
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying Percent. Range: 0 to 16.
End of interactive chart.
Past Year Prevalence of Serious Mental Illness Among U.S. Adults (2022)
Demographic
Percent
Overall
5.5
Sex
Female
7.0
Male
4.0
Age
18-25
11.4
26-49
7.1
50+
2.5
Race and Ethnicity
Hispanic or Latino*
5.1
White
6.1
Black or African American
4.3
Asian
2.8
NH/OPI
6.3
AI/AN
9.3
2 or More
8.2
* Persons of Hispanic origin may be of any race; all other racial/ethnic groups are non-Hispanic. NH/OPI = Native Hawaiian / Other Pacific Islander | AI/AN = American Indian / Alaskan Native.
Mental Health Treatment — SMI
Figure 4 presents data on mental health treatment received within the past year by U.S. adults 18 or older with serious mental illness (SMI). The NSDUH defines mental health treatment as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication to help with mental health.
In 2022, among the 15.4 million adults with SMI, 10.2 million (66.7%) received mental health treatment in the past year.
More females with SMI (71.4%) received mental health treatment than males with SMI (59.3%).
The percentage of young adults aged 18-25 years with SMI who received mental health treatment (61.4%) was lower than adults with SMI aged 26-49 years (67.4%) and aged 50 and older (71.0%).
Figure 4
Mental Health Treatment Received in Past Year Among U.S. Adults with Serious Mental Illness (2022)
Bar chart with 10 bars.
Data Courtesy of SAMHSA
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying Percent. Range: 0 to 80.
End of interactive chart.
Mental Health Treatment Received in Past Year Among U.S. Adults with Serious Mental Illness (2022)
Demographic
Percent
Overall
65.4
Sex
Female
67.6
Male
61.3
Age
18-25
57.9
26-49
67.0
50+
71.0
Race and Ethnicity
Hispanic or Latino*
58.6
White
68.6
Black or African American
62.3
Two or More Races
68.6
*Persons of Hispanic origin may be of any race; all other racial/ethnic groups are non-Hispanic. Note: Estimates for Asian, Native Hawaiian / Other Pacific Islander, and American Indian / Alaskan Native groups are not reported in the above figure due to low precision.
Prevalence of Any Mental Disorder Among Adolescents
Based on diagnostic interview data from National Comorbidity Survey Adolescent Supplement (NCS-A), Figure 5 shows lifetime prevalence of any mental disorder among U.S. adolescents aged 13-18.
1
An estimated 49.5% of adolescents had any mental disorder.
Of adolescents with any mental disorder, an estimated 22.2% had severe impairment and/or distress. DSM-IV based criteria were used to determine severity level.
Figure 5
Lifetime Prevalence of Any Mental Disorder Among Adolescents (2001-2004)
Bar chart with 7 bars.
Data from the National Comorbidity Survey Adolescent Supplement (NCS-A)
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying Percent. Range: 0 to 60.
End of interactive chart.
Lifetime Prevalence of Any Mental Disorder Among Adolescents (2001-2004)
Demographic
Percent
Overall
49.5
With Severe Impairment
22.2
Sex
Female
51.0
Male
48.1
Age
13-14
45.3
15-16
49.3
17-18
56.7
Data Sources
Merikangas KR, He JP, Burstein M, Swanson SA, Avenevoli S, Cui L, Benjet C, Georgiades K, Swendsen J. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A).
J Am Acad Child Adolesc Psychiatry.
2010 Oct;49(10):980-9.
PMID: 20855043Â
Substance Abuse and Mental Health Services Administration. (2023). Key substance use and mental health indicators in the United States: Results from the 2022Â National Survey on Drug Use and Health (HHS Publication No. PEP23-07-01-006, NSDUH Series H-58). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved fromÂ
https://www.samhsa.gov/data/report/2022-nsduh-annual-national-reportÂ
.
Statistical Methods and Measurement Caveats
National Survey on Drug Use and Health (NSDUH)
Diagnostic Assessment:
The NSDUH AMI and SMI estimates were generated from a prediction model created from clinical interview data collected on a subset of adult NSDUH respondents (4,912 total respondents between 2008 and 2012) who completed an adapted (past 12 month) version of the Structured Clinical Interview for DSM-IV-TR Axis I Disorders (Research Version, Non-patient Edition) (SCID-I/NP; First, Spitzer, Gibbon, & Williams, 2002), and was differentiated by level of functional impairment based on the Global Assessment of Functioning Scale (GAF; Endicott, Spitzer, Fleiss, & Cohen, 1976).
The assessment included diagnostic modules assessing the patients for the signs of: mood disorders (e.g., major depressive episode, manic episode), anxiety disorders (e.g., panic disorder, generalized anxiety disorder, posttraumatic stress disorder), eating disorders (e.g., anorexia nervosa), impulse control disorders (e.g. intermittent explosive disorder, and adjustment disorder), and a psychotic symptoms screen.
The assessment did not contain diagnostic modules assessing the following: adult attention deficit hyperactivity disorder (ADHD), autism spectrum disorders, schizophrenia or other psychotic disorders (although the assessment included a psychotic symptom screen).
People who only have disorders that are not included in these diagnostic modules may not be adequately detected. However, there are known patterns of high comorbidities among mental disorders; these patterns increase the likelihood that people who meet AMI and/or SMI criteria were detected by the study, as they may also have one or more of the disorders assessed in the SCID-I/NP.
Population:
The entirety of NSDUH respondents for the AMI and SMI estimates were the civilian, non-institutionalized population aged 18 years old or older residing within the United States.
The survey covered residents of households (persons living in houses/townhouses, apartments, condominiums; civilians living in housing on military bases, etc.) and persons in non-institutional group quarters (e.g., shelters, rooming/boarding houses, college dormitories, migratory workers' camps, and halfway houses).
The survey did not cover persons who, for the entire year, had no fixed address (e.g., persons experiencing homelessness and/or transient persons not in shelters); were on active military duty; or who resided in institutional group quarters (e.g., correctional facilities and long-term hospitals).
Some people in these excluded categories had AMI and/or SMI, but were not accounted for in the NSDUH AMI and/or SMI estimates.
Data regarding sex of the respondent was assessed using male and female categories only.
Survey Non-response:
In 2022, 52.0% of the selected NSDUH sample of people 18 or older did not complete the interview. This rate of non-response is higher than in years before 2020. Please see the Background on the 2022 NSDUH and the COVID-19 Pandemic section below for more information.
Reasons for non-response to interviewing include the following: refusal to participate (29.3%); respondent unavailable or never at home (18.2%); and other reasons such as physical/mental incompetence or language barriers (4.5%).
People with mental illness may disproportionately fall into these non-response categories. While NSDUH weighting includes non-response adjustments to reduce bias, these adjustments may not fully account for differential non-response by mental illness status.
Data Suppression:
For some groups, data are not reported due to low precision. Data may be suppressed in the above charts if the data do not meet acceptable ranges for prevalence estimates, standard error estimates, and sample size.
Background on the 2022 NSDUH and the COVID-19 Pandemic:
Data collection methods for the 2022Â NSDUH changed in several ways because of the COVID-19 pandemic: the 2022 NSDUH continued the use of multimode data collection procedures (both in-person and virtual data collection) that were first implemented in the fourth quarter of the 2020 NSDUH. Overall, 40.7% of interviews were completed via the web, and 59.3% were completed in person. In 2022, the weighted response rates for household screening and for interviewing were 25.5% and 47.4%, respectively, for an overall response rate of 12.1% for people aged 12 or older.
Given the use of multimode data collection procedures throughout the entirety of the collection year and the rate of non-response, comparison of estimates from the 2022 NSDUH with those from prior years must be made with caution.
Please see theÂ
2022 National Survey on Drug Use and Health Methodological Summary and Definitions reportÂ
for further information on how these data were collected and calculated.
National Comorbidity Survey Adolescent Supplement (NCS-A)
Diagnostic Assessment and Population:
The NCS-A was carried out under a cooperative agreement sponsored by NIMH to meet a request from Congress to provide national data on the prevalence and correlates of mental disorders among U.S. youth. The NCS-A was a nationally representative, face-to-face survey of 10,123 adolescents aged 13 to 18 years in the continental United States. The survey was based on a dual-frame design that included 904 adolescent residents of the households that participated in the adult U.S. National Comorbidity Survey Replication and 9,244 adolescent students selected from a nationally representative sample of 320 schools. The survey was fielded between February 2001 and January 2004. DSM-IV mental disorders were assessed using a modified version of the fully structured World Health Organization Composite International Diagnostic Interview.
Survey Non-response:
The overall adolescent non-response rate was 24.4%. This is made up of non-response rates of 14.1% in the household sample, 18.2% in the un-blinded school sample, and 77.7% in the blinded school sample. Non-response was largely due to refusal (21.3%), which in the household and un-blinded school samples came largely from parents rather than adolescents (72.3% and 81.0%, respectively). The refusals in the blinded school sample, in comparison, came almost entirely (98.1%) from parents failing to return the signed consent postcard.
For more information, seeÂ
PMID: 19507169Â
 and the
NIMH NCS-A study page
.
Last Updated: September 2024 |
| Markdown | [Skip to main content](https://www.nimh.nih.gov/health/statistics/mental-illness#main-content)
An official website of the United States government
Here’s how you know
Here’s how you know
**Official websites use .gov**
A **.gov** website belongs to an official government organization in the United States.
**Secure .gov websites use HTTPS**
A **lock** ( Locked padlock icon) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Due to current HHS and NIH restructuring, some content on nimh.nih.gov is not being updated regularly. Please refer to [clinicaltrials.gov](https://clinicaltrials.gov/) and [nih.gov](https://www.nih.gov/about-nih/nih-director/statements/nih-launches-initiative-modernize-strengthen-biosafety-oversight) for up-to-date information on NIH research.
[](https://www.nimh.nih.gov/ "NIMH Home")
[In Crisis? Call or Text 988](https://988lifeline.org/)
Transforming the understanding
and treatment of mental illnesses.
[Home](https://www.nimh.nih.gov/) \| [Help for Mental Illnesses](https://www.nimh.nih.gov/health/find-help)
[Información en español](https://www.nimh.nih.gov/health/topics/espanol)
- [Mental Health Information](https://www.nimh.nih.gov/health)
- [Get Involved](https://www.nimh.nih.gov/get-involved)
- [Research](https://www.nimh.nih.gov/research)
- [Funding](https://www.nimh.nih.gov/funding)
- [News & Events](https://www.nimh.nih.gov/news)
- [About Us](https://www.nimh.nih.gov/about)
[Health Topics NIMH offers expert-reviewed information on mental disorders and a range of topics.](https://www.nimh.nih.gov/health/topics)
[Statistics NIMH statistics pages include statistics on the prevalence, treatment, and costs of mental illness for the population of the United States.](https://www.nimh.nih.gov/health/statistics)
[Brochures and Fact Sheets Download, read, and order free NIMH brochures and fact sheets about mental disorders and related topics.](https://www.nimh.nih.gov/health/publications)
[Help for Mental Illnesses If you or someone you know has a mental illness, there are ways to get help. Use these resources to find help for yourself, a friend, or a family member.](https://www.nimh.nih.gov/health/find-help)
[Clinical Trials If you or a friend or family member are thinking about taking part in clinical research, this page contains basic information about clinical trials.](https://www.nimh.nih.gov/health/trials)
[Stakeholder Engagement Find out how NIMH engages a range of stakeholder organizations as part of its efforts to ensure the greatest public health impact of the research we support.](https://www.nimh.nih.gov/get-involved/public-involvement)
[Connect with NIMH Learn more about NIMH newsletters, public participation in grant reviews, research funding, clinical trials, the NIMH Gift Fund, and connecting with NIMH on social media.](https://www.nimh.nih.gov/get-involved/connect-with-nimh)
[Digital Shareables Use these free education and outreach materials in your community and on social media to spread the word about mental health and related topics.](https://www.nimh.nih.gov/get-involved/digital-shareables)
[Science Education Use these free digital, outreach materials in your community and on social media to spread the word about mental health.](https://www.nimh.nih.gov/get-involved/science-education)
[Research Funded by NIMH NIMH supports research at universities, medical centers, and other institutions via grants, contracts, and cooperative agreements. Learn more about NIMH research areas, policies, resources, and initiatives.](https://www.nimh.nih.gov/research/research-funded-by-nimh)
[Research Conducted at NIMH (Intramural Research Program) The Division of Intramural Research Programs (IRP) is the internal research division of the NIMH. Over 40 research groups conduct basic neuroscience research and clinical investigations of mental illnesses, brain function, and behavior at the NIH campus in Bethesda, Maryland. Learn more about research conducted at NIMH.](https://www.nimh.nih.gov/research/research-conducted-at-nimh)
[Priority Research Areas Learn about NIMH priority areas for research and funding that have the potential to improve mental health care over the short, medium, and long term.](https://www.nimh.nih.gov/research/priority-research-areas)
[Resources for Researchers Information about resources such as data, tissue, model organisms and imaging resources to support the NIMH research community.](https://www.nimh.nih.gov/research/research-funded-by-nimh/research-resources)
[Opportunities & Announcements Find all NIMH and cross-NIH funding opportunities.](https://www.nimh.nih.gov/funding/opportunities-announcements)
[Funding Strategy for Grants Read more about the NIMH Strategic Plan for Research, Strategic Research Priorities, the anatomy of NIMH funding, and our yearly funding strategy for research grants.](https://www.nimh.nih.gov/funding/funding-strategy-for-research-grants)
[Application Process Explore the NIMH grant application process, including how to write your grant, how to submit your grant, and how the review process works.](https://www.nimh.nih.gov/funding/grant-writing-and-application-process)
[Managing Grants Learn about how NIMH manages research grants, including policies and reporting requirements.](https://www.nimh.nih.gov/funding/managing-your-grant)
[Clinical Research Find the latest NIH and NIMH policies, guidance, and resources for clinical research.](https://www.nimh.nih.gov/funding/clinical-research)
[Training Explore NIMH research training and career development opportunities.](https://www.nimh.nih.gov/funding/training)
[Small Business Research Learn about funding opportunities for small businesses.](https://www.nimh.nih.gov/funding/sbir)
### Quick Links
[Funding & Grant News](https://www.nimh.nih.gov/funding/opportunities-announcements/funding-grant-news)
[Support for Clinical Trials at NIMH](https://www.nimh.nih.gov/funding/opportunities-announcements/clinical-trials-foas)
[Science Updates List of NIMH science updates including press releases, research highlights, and institute announcements.](https://www.nimh.nih.gov/news/science-updates)
[Meetings and Events Details about upcoming events—including meetings, conferences, workshops, lectures, webinars, and chats—sponsored by NIMH.](https://www.nimh.nih.gov/news/events)
[Multimedia NIMH videos and podcasts featuring science news, lecture series, meetings, seminars, and special events.](https://www.nimh.nih.gov/news/media)
[Innovation Speaker Series An annual lecture series dedicated to innovation, invention, and scientific discovery.](https://www.nimh.nih.gov/news/innovation-speaker-series)
[About the Acting NIMH Director Learn more about the Acting Director of the NIMH, Shelli Avenevoli, Ph.D.](https://www.nimh.nih.gov/about/director)
[Advisory Boards and Groups Read about the boards and groups that advise and provide guidance to the Institute.](https://www.nimh.nih.gov/about/advisory-boards-and-groups)
[Strategic Plan Learn more about NIMH's roadmap for the Institute’s research priorities over the next five years.](https://www.nimh.nih.gov/about/strategic-planning-reports)
[Offices and Divisions Learn more about the functions of each NIMH office and division.](https://www.nimh.nih.gov/about/organization)
[Budget Read the annual NIMH Congressional Justifications.](https://www.nimh.nih.gov/about/budget)
[Careers at NIMH Search for jobs, including scientific, administrative and executive careers at NIMH.](https://www.nimh.nih.gov/about/careers)
[Staff Directories Find the names, telephone numbers, email addresses, and office locations of NIMH staff.](https://www.nimh.nih.gov/about/staff-directories)
[History Explore key milestones, discoveries, and the impact of NIMH-funded studies on mental health.](https://www.nimh.nih.gov/about/nimh-history)
[Getting to NIMH Find directions, maps, parking information, and other visitor information for NIMH.](https://www.nimh.nih.gov/about/connect-with-nimh)
### Quick Links
**[Contribute to Mental Health Research](https://www.nimh.nih.gov/about/connect-with-nimh/donate-to-mental-health-research "Donate to Mental Health Research")**
- [Mental Health Information](https://www.nimh.nih.gov/health)
- [Mental Health Information Home](https://www.nimh.nih.gov/health)
- [Health Topics](https://www.nimh.nih.gov/health/topics)
- [Statistics](https://www.nimh.nih.gov/health/statistics)
- [Brochures and Fact Sheets](https://www.nimh.nih.gov/health/publications)
- [Help for Mental Illnesses](https://www.nimh.nih.gov/health/find-help)
- [Clinical Trials](https://www.nimh.nih.gov/health/trials)
- [Get Involved](https://www.nimh.nih.gov/get-involved)
- [Get Involved Home](https://www.nimh.nih.gov/get-involved)
- [Stakeholder Engagement](https://www.nimh.nih.gov/get-involved/public-involvement)
- [Connect with NIMH](https://www.nimh.nih.gov/get-involved/connect-with-nimh)
- [Digital Shareables](https://www.nimh.nih.gov/get-involved/digital-shareables)
- [Science Education](https://www.nimh.nih.gov/get-involved/science-education)
- [Research](https://www.nimh.nih.gov/research)
- [Research Home](https://www.nimh.nih.gov/research)
- [Research Funded by NIMH](https://www.nimh.nih.gov/research/research-funded-by-nimh)
- [Research Conducted at NIMH (Intramural Research Program)](https://www.nimh.nih.gov/research/research-conducted-at-nimh)
- [Funding](https://www.nimh.nih.gov/funding)
- [Funding Home](https://www.nimh.nih.gov/funding)
- [Opportunities & Announcements](https://www.nimh.nih.gov/funding/opportunities-announcements)
- [Strategy for Research Grants](https://www.nimh.nih.gov/funding/funding-strategy-for-research-grants/strategy-for-research-grants)
- [Grant Writing & Approval Process](https://www.nimh.nih.gov/funding/grant-writing-and-application-process)
- [Managing Grants](https://www.nimh.nih.gov/funding/managing-your-grant)
- [Clinical Research](https://www.nimh.nih.gov/funding/clinical-research)
- [Research Training and Career Development Opportunities](https://www.nimh.nih.gov/funding/training)
- [Small Business Research](https://www.nimh.nih.gov/funding/sbir)
- [News & Events](https://www.nimh.nih.gov/news)
- [News & Events Home](https://www.nimh.nih.gov/news)
- [Science Updates](https://www.nimh.nih.gov/news/science-updates)
- [Meetings and Events](https://www.nimh.nih.gov/news/events)
- [Multimedia](https://www.nimh.nih.gov/news/media)
- [Social Media](https://www.nimh.nih.gov/news/social-media)
- [Email Updates](https://www.nimh.nih.gov/news/email-updates)
- [Innovation Speaker Series](https://www.nimh.nih.gov/news/innovation-speaker-series)
- [About Us](https://www.nimh.nih.gov/about)
- [About Us Home](https://www.nimh.nih.gov/about)
- [About the Acting NIMH Director](https://www.nimh.nih.gov/about/director)
- [Advisory Boards and Groups](https://www.nimh.nih.gov/about/advisory-boards-and-groups)
- [Strategic Plan](https://www.nimh.nih.gov/about/strategic-planning-reports)
- [Offices and Divisions](https://www.nimh.nih.gov/about/organization)
- [Budget](https://www.nimh.nih.gov/about/budget)
- [Careers at NIMH](https://www.nimh.nih.gov/about/careers)
- [Staff Directories](https://www.nimh.nih.gov/about/staff-directories)
- [History](https://www.nimh.nih.gov/about/nimh-history)
- [Getting to NIMH](https://www.nimh.nih.gov/about/connect-with-nimh)
- [Health Topics](https://www.nimh.nih.gov/health/topics)
- [Statistics](https://www.nimh.nih.gov/health/statistics)
- [Brochures and Fact Sheets](https://www.nimh.nih.gov/health/publications)
- [Help for Mental Illnesses](https://www.nimh.nih.gov/health/find-help)
- [Clinical Trials](https://www.nimh.nih.gov/health/trials)
[Home](https://www.nimh.nih.gov/) \> [Mental Health Information](https://www.nimh.nih.gov/health) \> [Statistics](https://www.nimh.nih.gov/health/statistics) \> Mental Illness
###### Share Page
Menu
- [Definitions](https://www.nimh.nih.gov/health/statistics/mental-illness#part_2538)
- [Prevalence of Any Mental Illness (AMI)](https://www.nimh.nih.gov/health/statistics/mental-illness#part_2539)
- [Mental Health Treatment — AMI](https://www.nimh.nih.gov/health/statistics/mental-illness#part_2540)
- [Prevalence of Serious Mental Illness (SMI)](https://www.nimh.nih.gov/health/statistics/mental-illness#part_2541)
- [Mental Health Treatment — SMI](https://www.nimh.nih.gov/health/statistics/mental-illness#part_2542)
- [Prevalence of Any Mental Disorder Among Adolescents](https://www.nimh.nih.gov/health/statistics/mental-illness#part_2632)
- [Data Sources](https://www.nimh.nih.gov/health/statistics/mental-illness#part_2555)
# Mental Illness
Mental illnesses are common in the United States and around the world. It is estimated that more than one in five U.S. adults live with a mental illness (59.3 million in 2022; 23.1% of the U.S. adult population). Mental illnesses include many different conditions that vary in degree of severity, ranging from mild to moderate to severe. Two broad categories can be used to describe these conditions: Any Mental Illness (AMI) and Serious Mental Illness (SMI). AMI encompasses all recognized mental illnesses. SMI is a smaller and more severe subset of AMI. Additional information on mental illnesses can be found on the [NIMH Health Topics Pages](https://www.nimh.nih.gov/health/topics).
## Definitions
The data presented here are from the [2022 National Survey on Drug Use and Health (NSDUH)](https://www.samhsa.gov/data/release/2022-national-survey-drug-use-and-health-nsduh-releases) by the [Substance Abuse and Mental Health Services Administration](http://www.samhsa.gov/) (SAMHSA). For inclusion in NSDUH prevalence estimates, mental illnesses include those that are diagnosable currently or within the past year; of sufficient duration to meet diagnostic criteria specified within the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV); and, exclude developmental and substance use disorders.
### Any Mental Illness
- **Any mental illness (AMI)** is defined as a mental, behavioral, or emotional disorder. AMI can vary in impact, ranging from no impairment to mild, moderate, and even severe impairment (e.g., individuals with serious mental illness as defined below).
### Serious Mental Illness
- **Serious mental illness (SMI)** is defined as a mental, behavioral, or emotional disorder resulting in serious functional impairment, which substantially interferes with or limits one or more major life activities. The burden of mental illnesses is particularly concentrated among those who experience disability due to SMI.
## Prevalence of Any Mental Illness (AMI)
- Figure 1 shows the past year prevalence of AMI among U.S. adults.
- In 2022, there were an estimated 59.3 million adults aged 18 or older in the United States with AMI. This number represented 23.1% of all U.S. adults.
- The observed prevalence of AMI was higher among females (26.4%) than males (19.7%).
- Young adults aged 18-25 years had the highest prevalence of AMI (36.2%) compared to adults aged 26-49 years (29.4%) and aged 50 and older (13.9%).
- The prevalence of AMI was highest among the adults reporting two or more races (35.2%), followed by White adults (24.6%). The prevalence of AMI was lowest among Asian adults (16.8%).
#### Figure 1
Past Year Prevalence of Any Mental Illness Among U.S. Adults (2022)
Bar chart with 12 bars.
Data Courtesy of SAMHSA
View as data table, Past Year Prevalence of Any Mental Illness Among U.S. Adults (2022)
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying Percent. Range: 0 to 40.
Created with Highcharts 9.0.1
Percent
Past Year Prevalence of Any Mental Illness Among U.S. Adults (2022)
Data Courtesy of SAMHSA
23\.1
​
23\.1
26\.4
​
26\.4
19\.7
​
19\.7
36\.2
​
36\.2
29\.4
​
29\.4
13\.9
​
13\.9
21\.4
​
21\.4
24\.6
​
24\.6
19\.7
​
19\.7
19\.6
​
19\.6
16\.8
​
16\.8
35\.2
​
35\.2
Overall
Female
Sex
Male
18-25
Age
26-49
50+
Hispan…
Race and Ethnicity
White
Black …
AI/AN
Asian
2 or M…
0
5
10
15
20
25
30
35
40
End of interactive chart.
| Demographic | Percent | |
|---|---|---|
| Overall | 23\.1 | |
| Sex | Female | 26\.4 |
| Male | 19\.7 | |
| Age | 18-25 | 36\.2 |
| 26-49 | 29\.4 | |
| 50+ | 13\.9 | |
| Race and Ethnicity | Hispanic or Latino\* | 21\.4 |
| White | 24\.6 | |
| Black or African American | 19\.7 | |
| AI/AN | 19,6 | |
| Asian | 16\.8 | |
| 2 or More | 35\.2 | |
\*Persons of Hispanic origin may be of any race; all other racial/ethnic groups are non-Hispanic. AI/AN = American Indian / Alaskan Native
\*\*Note: Estimates for the Native Hawaiian / Other Pacific Islander group are not reported in the above figure due to low precision of data collection in 2022.
## Mental Health Treatment — AMI
- Figure 2 presents data on mental health treatment received within the past year by U.S. adults aged 18 or older with any mental illness (AMI). NSDUH defines mental health treatment as having received inpatient treatment/counseling or outpatient treatment/counseling, or having used prescription medication to help with mental health.
- In 2022, among the 59.3 million adults with AMI, 30.0 million (50.6%) received mental health treatment in the past year.
- More females with AMI (56.9%) received mental health treatment than males with AMI (41.6%).
- The percentage of young adults aged 18-25 years with AMI who received mental health treatment (49.1%) was slightly lower than adults with AMI aged 26-49 years (50.0%) and aged 50 and older (52.7%).
#### Figure 2
Mental Health Treatment Received in Past Year Among U.S. Adults with Any Mental Illness (2022)
Bar chart with 11 bars.
Data Courtesy of SAMHSA
View as data table, Mental Health Treatment Received in Past Year Among U.S. Adults with Any Mental Illness (2022)
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying Percent. Range: 0 to 60.
Created with Highcharts 9.0.1
Percent
Mental Health Treatment Received in Past Year Among U.S. Adults
​
with
​
Any Mental Illness (2022)
Data Courtesy of SAMHSA
50\.6
​
50\.6
56\.9
​
56\.9
41\.6
​
41\.6
49\.1
​
49\.1
50\.0
​
50\.0
52\.7
​
52\.7
39\.6
​
39\.6
56\.1
​
56\.1
37\.9
​
37\.9
56\.0
​
56\.0
36\.1
​
36\.1
Overall
Female
Sex
Male
18-25
Age
26-49
50+
Hispani…
Race and Ethnicity
White
Black o…
Two or …
Asian
0
10
20
30
40
50
60
End of interactive chart.
| Demographic | Percent | |
|---|---|---|
| Overall | 50\.6 | |
| Sex | Female | 56\.9 |
| Male | 41\.6 | |
| Age | 18-25 | 49\.1 |
| 26-49 | 50\.0 | |
| 50+ | 52\.7 | |
| Race and Ethnicity | Hispanic or Latino\* | 39\.6 |
| White | 56\.1 | |
| Black or African American | 37\.9 | |
| Two or More Races | 56\.0 | |
| Asian | 36\.1 | |
\*Persons of Hispanic origin may be of any race; all other racial/ethnic groups are non-Hispanic. Note: Estimates for the Native Hawaiian / Other Pacific Islander group is not reported in the above figure due to low precision of data collection in 2022.
## Prevalence of Serious Mental Illness (SMI)
- Figure 3 shows the past year prevalence of SMI among U.S. adults.
- In 2022, there were an estimated 15.4 million adults aged 18 or older in the United States with SMI. This number represented 6.0% of all U.S. adults.
- The observed prevalence of SMI was higher among females (7.1%) than males (4.8%).
- Young adults aged 18-25 years had the highest prevalence of SMI (11.6%) compared to adults aged 26-49 years (7.6%) and aged 50 and older (3.0%).
- The prevalence of SMI was highest among adults reporting two or more races (11.8%), followed by American Indian / Alaskan Native (AI/AN) adults (7.3%). The prevalence of SMI was lowest among Native Hawaiian / Other Pacific Islander (NH/OPI) adults (3.5%).
#### Figure 3
Past Year Prevalence of Serious Mental Illness Among U.S. Adults (2022)
Bar chart with 13 bars.
Data Courtesy of SAMHSA
View as data table, Past Year Prevalence of Serious Mental Illness Among U.S. Adults (2022)
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying Percent. Range: 0 to 16.
Created with Highcharts 9.0.1
Percent
Past Year Prevalence of Serious Mental Illness Among U.S. Adults
​
(2022)
Data Courtesy of SAMHSA
6\.0
​
6\.0
7\.1
​
7\.1
4\.8
​
4\.8
11\.6
​
11\.6
7\.6
​
7\.6
3\.0
​
3\.0
5\.3
​
5\.3
6\.5
​
6\.5
4\.7
​
4\.7
4\.1
​
4\.1
3\.5
​
3\.5
7\.3
​
7\.3
11\.8
​
11\.8
Overall
Female
Sex
Male
18-25
Age
26-49
50+
Hispa…
Race and Ethnicity
White
Black …
Asian
NH/OPI
AI/AN
2 or …
0
2
4
6
8
10
12
14
16
End of interactive chart.
| Demographic | Percent | |
|---|---|---|
| Overall | 5\.5 | |
| Sex | Female | 7\.0 |
| Male | 4\.0 | |
| Age | 18-25 | 11\.4 |
| 26-49 | 7\.1 | |
| 50+ | 2\.5 | |
| Race and Ethnicity | Hispanic or Latino\* | 5\.1 |
| White | 6\.1 | |
| Black or African American | 4\.3 | |
| Asian | 2\.8 | |
| NH/OPI | 6\.3 | |
| AI/AN | 9\.3 | |
| 2 or More | 8\.2 | |
\* Persons of Hispanic origin may be of any race; all other racial/ethnic groups are non-Hispanic. NH/OPI = Native Hawaiian / Other Pacific Islander \| AI/AN = American Indian / Alaskan Native.
## Mental Health Treatment — SMI
- Figure 4 presents data on mental health treatment received within the past year by U.S. adults 18 or older with serious mental illness (SMI). The NSDUH defines mental health treatment as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication to help with mental health.
- In 2022, among the 15.4 million adults with SMI, 10.2 million (66.7%) received mental health treatment in the past year.
- More females with SMI (71.4%) received mental health treatment than males with SMI (59.3%).
- The percentage of young adults aged 18-25 years with SMI who received mental health treatment (61.4%) was lower than adults with SMI aged 26-49 years (67.4%) and aged 50 and older (71.0%).
#### Figure 4
Mental Health Treatment Received in Past Year Among U.S. Adults with Serious Mental Illness (2022)
Bar chart with 10 bars.
Data Courtesy of SAMHSA
View as data table, Mental Health Treatment Received in Past Year Among U.S. Adults with Serious Mental Illness (2022)
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying Percent. Range: 0 to 80.
Created with Highcharts 9.0.1
Percent
Mental Health Treatment Received in Past Year Among U.S. Adults
​
with
​
Serious Mental Illness (2022)
Data Courtesy of SAMHSA
66\.7
​
66\.7
71\.4
​
71\.4
59\.3
​
59\.3
61\.4
​
61\.4
67\.4
​
67\.4
71\.0
​
71\.0
58\.4
​
58\.4
71\.4
​
71\.4
52\.3
​
52\.3
73\.9
​
73\.9
Overall
Female
Sex
Male
18-25
Age
26-49
50+
Hispanic…
Race and Ethnicity
White
Black or …
Two or …
0
10
20
30
40
50
60
70
80
End of interactive chart.
| Demographic | Percent | |
|---|---|---|
| Overall | 65\.4 | |
| Sex | Female | 67\.6 |
| Male | 61\.3 | |
| Age | 18-25 | 57\.9 |
| 26-49 | 67\.0 | |
| 50+ | 71\.0 | |
| Race and Ethnicity | Hispanic or Latino\* | 58\.6 |
| White | 68\.6 | |
| Black or African American | 62\.3 | |
| Two or More Races | 68\.6 | |
\*Persons of Hispanic origin may be of any race; all other racial/ethnic groups are non-Hispanic. Note: Estimates for Asian, Native Hawaiian / Other Pacific Islander, and American Indian / Alaskan Native groups are not reported in the above figure due to low precision.
## Prevalence of Any Mental Disorder Among Adolescents
- Based on diagnostic interview data from National Comorbidity Survey Adolescent Supplement (NCS-A), Figure 5 shows lifetime prevalence of any mental disorder among U.S. adolescents aged 13-18.1
- An estimated 49.5% of adolescents had any mental disorder.
- Of adolescents with any mental disorder, an estimated 22.2% had severe impairment and/or distress. DSM-IV based criteria were used to determine severity level.
#### Figure 5
Lifetime Prevalence of Any Mental Disorder Among Adolescents (2001-2004)
Bar chart with 7 bars.
Data from the National Comorbidity Survey Adolescent Supplement (NCS-A)
View as data table, Lifetime Prevalence of Any Mental Disorder Among Adolescents (2001-2004)
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying Percent. Range: 0 to 60.
Created with Highcharts 9.0.1
Percent
Lifetime Prevalence of Any Mental Disorder Among Adolescents
​
(2001-2004)
Data from the National Comorbidity Survey Adolescent Supplement (NCS-A)
49\.5
​
49\.5
22\.2
​
22\.2
51\.0
​
51\.0
48\.1
​
48\.1
45\.3
​
45\.3
49\.3
​
49\.3
56\.7
​
56\.7
Overall
With Severe I…
Female
Sex
Male
13-14
Age
15-16
17-18
0
10
20
30
40
50
60
End of interactive chart.
| Demographic | Percent | |
|---|---|---|
| Overall | 49\.5 | |
| With Severe Impairment | 22\.2 | |
| Sex | Female | 51\.0 |
| Male | 48\.1 | |
| Age | 13-14 | 45\.3 |
| 15-16 | 49\.3 | |
| 17-18 | 56\.7 | |
## Data Sources
1. Merikangas KR, He JP, Burstein M, Swanson SA, Avenevoli S, Cui L, Benjet C, Georgiades K, Swendsen J. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A). *J Am Acad Child Adolesc Psychiatry.* 2010 Oct;49(10):980-9. [PMID: 20855043](http://www.ncbi.nlm.nih.gov/pubmed/20855043/)
2. Substance Abuse and Mental Health Services Administration. (2023). Key substance use and mental health indicators in the United States: Results from the 2022 National Survey on Drug Use and Health (HHS Publication No. PEP23-07-01-006, NSDUH Series H-58). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from <https://www.samhsa.gov/data/report/2022-nsduh-annual-national-report>.
### Statistical Methods and Measurement Caveats
#### National Survey on Drug Use and Health (NSDUH)
Diagnostic Assessment:
- The NSDUH AMI and SMI estimates were generated from a prediction model created from clinical interview data collected on a subset of adult NSDUH respondents (4,912 total respondents between 2008 and 2012) who completed an adapted (past 12 month) version of the Structured Clinical Interview for DSM-IV-TR Axis I Disorders (Research Version, Non-patient Edition) (SCID-I/NP; First, Spitzer, Gibbon, & Williams, 2002), and was differentiated by level of functional impairment based on the Global Assessment of Functioning Scale (GAF; Endicott, Spitzer, Fleiss, & Cohen, 1976).
- The assessment included diagnostic modules assessing the patients for the signs of: mood disorders (e.g., major depressive episode, manic episode), anxiety disorders (e.g., panic disorder, generalized anxiety disorder, posttraumatic stress disorder), eating disorders (e.g., anorexia nervosa), impulse control disorders (e.g. intermittent explosive disorder, and adjustment disorder), and a psychotic symptoms screen.
- The assessment did not contain diagnostic modules assessing the following: adult attention deficit hyperactivity disorder (ADHD), autism spectrum disorders, schizophrenia or other psychotic disorders (although the assessment included a psychotic symptom screen).
- People who only have disorders that are not included in these diagnostic modules may not be adequately detected. However, there are known patterns of high comorbidities among mental disorders; these patterns increase the likelihood that people who meet AMI and/or SMI criteria were detected by the study, as they may also have one or more of the disorders assessed in the SCID-I/NP.
Population:
- The entirety of NSDUH respondents for the AMI and SMI estimates were the civilian, non-institutionalized population aged 18 years old or older residing within the United States.
- The survey covered residents of households (persons living in houses/townhouses, apartments, condominiums; civilians living in housing on military bases, etc.) and persons in non-institutional group quarters (e.g., shelters, rooming/boarding houses, college dormitories, migratory workers' camps, and halfway houses).
- The survey did not cover persons who, for the entire year, had no fixed address (e.g., persons experiencing homelessness and/or transient persons not in shelters); were on active military duty; or who resided in institutional group quarters (e.g., correctional facilities and long-term hospitals).
- Some people in these excluded categories had AMI and/or SMI, but were not accounted for in the NSDUH AMI and/or SMI estimates.
- Data regarding sex of the respondent was assessed using male and female categories only.
Survey Non-response:
- In 2022, 52.0% of the selected NSDUH sample of people 18 or older did not complete the interview. This rate of non-response is higher than in years before 2020. Please see the Background on the 2022 NSDUH and the COVID-19 Pandemic section below for more information.
- Reasons for non-response to interviewing include the following: refusal to participate (29.3%); respondent unavailable or never at home (18.2%); and other reasons such as physical/mental incompetence or language barriers (4.5%).
- People with mental illness may disproportionately fall into these non-response categories. While NSDUH weighting includes non-response adjustments to reduce bias, these adjustments may not fully account for differential non-response by mental illness status.
Data Suppression:
- For some groups, data are not reported due to low precision. Data may be suppressed in the above charts if the data do not meet acceptable ranges for prevalence estimates, standard error estimates, and sample size.
Background on the 2022 NSDUH and the COVID-19 Pandemic:
- Data collection methods for the 2022 NSDUH changed in several ways because of the COVID-19 pandemic: the 2022 NSDUH continued the use of multimode data collection procedures (both in-person and virtual data collection) that were first implemented in the fourth quarter of the 2020 NSDUH. Overall, 40.7% of interviews were completed via the web, and 59.3% were completed in person. In 2022, the weighted response rates for household screening and for interviewing were 25.5% and 47.4%, respectively, for an overall response rate of 12.1% for people aged 12 or older.
- Given the use of multimode data collection procedures throughout the entirety of the collection year and the rate of non-response, comparison of estimates from the 2022 NSDUH with those from prior years must be made with caution.
Please see the [2022 National Survey on Drug Use and Health Methodological Summary and Definitions report](https://www.samhsa.gov/data/report/2022-methodological-summary-and-definitions) for further information on how these data were collected and calculated.
#### National Comorbidity Survey Adolescent Supplement (NCS-A)
Diagnostic Assessment and Population:
- The NCS-A was carried out under a cooperative agreement sponsored by NIMH to meet a request from Congress to provide national data on the prevalence and correlates of mental disorders among U.S. youth. The NCS-A was a nationally representative, face-to-face survey of 10,123 adolescents aged 13 to 18 years in the continental United States. The survey was based on a dual-frame design that included 904 adolescent residents of the households that participated in the adult U.S. National Comorbidity Survey Replication and 9,244 adolescent students selected from a nationally representative sample of 320 schools. The survey was fielded between February 2001 and January 2004. DSM-IV mental disorders were assessed using a modified version of the fully structured World Health Organization Composite International Diagnostic Interview.
Survey Non-response:
- The overall adolescent non-response rate was 24.4%. This is made up of non-response rates of 14.1% in the household sample, 18.2% in the un-blinded school sample, and 77.7% in the blinded school sample. Non-response was largely due to refusal (21.3%), which in the household and un-blinded school samples came largely from parents rather than adolescents (72.3% and 81.0%, respectively). The refusals in the blinded school sample, in comparison, came almost entirely (98.1%) from parents failing to return the signed consent postcard.
For more information, see [PMID: 19507169](https://www.ncbi.nlm.nih.gov/pubmed/19507169) and the [NIMH NCS-A study page](https://www.nimh.nih.gov/news/science-updates/2010/national-survey-confirms-that-youth-are-disproportionately-affected-by-mental-disorders).
Last Updated: September 2024
## Disclaimer
We link to external websites for informational purposes only, but we do not endorse or guarantee their accuracy. Once you leave our site, you will be subject to the new website’s privacy policy. Read NIMH’s [full external linking policy](https://www.nimh.nih.gov/site-info/policies#part_2717) for more information.
##### NIMH Resources
[Health Topics](https://www.nimh.nih.gov/health/topics)
[Brochures and Fact Sheets](https://www.nimh.nih.gov/health/publications)
[Contact Us](https://www.nimh.nih.gov/site-info/contact-nimh)
[Información en español](https://www.nimh.nih.gov/health/topics/espanol)
##### Policies and Notices
[Privacy Policy](https://www.nimh.nih.gov/site-info/privacy-policy)
[Website Policies](https://www.nimh.nih.gov/site-info/policies)
[FOIA](http://www.nih.gov/icd/od/foia/index.htm)
[Accessibility](https://www.nimh.nih.gov/site-info/accessibility)
[HHS Vulnerability Disclosure](https://www.hhs.gov/vulnerability-disclosure-policy/index.html)
##### Federal Resources
[National Institutes of Health (NIH)](http://www.nih.gov/)
[NIH Virtual Tour](https://www.nih.gov/virtual-tour/)
[U.S. Department of Health and Human Services](https://www.hhs.gov/)
[USA.gov](http://www.usa.gov/)
The National Institute of Mental Health (NIMH) is part of NIH, a component of the U.S. Department of Health and Human Services.
[Top](https://www.nimh.nih.gov/health/statistics/mental-illness#skipnav) |
| Readable Markdown | Mental illnesses are common in the United States and around the world. It is estimated that more than one in five U.S. adults live with a mental illness (59.3 million in 2022; 23.1% of the U.S. adult population). Mental illnesses include many different conditions that vary in degree of severity, ranging from mild to moderate to severe. Two broad categories can be used to describe these conditions: Any Mental Illness (AMI) and Serious Mental Illness (SMI). AMI encompasses all recognized mental illnesses. SMI is a smaller and more severe subset of AMI. Additional information on mental illnesses can be found on the [NIMH Health Topics Pages](https://www.nimh.nih.gov/health/topics).
## Definitions
The data presented here are from the [2022 National Survey on Drug Use and Health (NSDUH)](https://www.samhsa.gov/data/release/2022-national-survey-drug-use-and-health-nsduh-releases) by the [Substance Abuse and Mental Health Services Administration](http://www.samhsa.gov/) (SAMHSA). For inclusion in NSDUH prevalence estimates, mental illnesses include those that are diagnosable currently or within the past year; of sufficient duration to meet diagnostic criteria specified within the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV); and, exclude developmental and substance use disorders.
### Any Mental Illness
- **Any mental illness (AMI)** is defined as a mental, behavioral, or emotional disorder. AMI can vary in impact, ranging from no impairment to mild, moderate, and even severe impairment (e.g., individuals with serious mental illness as defined below).
### Serious Mental Illness
- **Serious mental illness (SMI)** is defined as a mental, behavioral, or emotional disorder resulting in serious functional impairment, which substantially interferes with or limits one or more major life activities. The burden of mental illnesses is particularly concentrated among those who experience disability due to SMI.
## Prevalence of Any Mental Illness (AMI)
- Figure 1 shows the past year prevalence of AMI among U.S. adults.
- In 2022, there were an estimated 59.3 million adults aged 18 or older in the United States with AMI. This number represented 23.1% of all U.S. adults.
- The observed prevalence of AMI was higher among females (26.4%) than males (19.7%).
- Young adults aged 18-25 years had the highest prevalence of AMI (36.2%) compared to adults aged 26-49 years (29.4%) and aged 50 and older (13.9%).
- The prevalence of AMI was highest among the adults reporting two or more races (35.2%), followed by White adults (24.6%). The prevalence of AMI was lowest among Asian adults (16.8%).
#### Figure 1
Past Year Prevalence of Any Mental Illness Among U.S. Adults (2022)
Bar chart with 12 bars.
Data Courtesy of SAMHSA
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying Percent. Range: 0 to 40.
End of interactive chart.
| Demographic | Percent | |
|---|---|---|
| Overall | 23\.1 | |
| Sex | Female | 26\.4 |
| Male | 19\.7 | |
| Age | 18-25 | 36\.2 |
| 26-49 | 29\.4 | |
| 50+ | 13\.9 | |
| Race and Ethnicity | Hispanic or Latino\* | 21\.4 |
| White | 24\.6 | |
| Black or African American | 19\.7 | |
| AI/AN | 19,6 | |
| Asian | 16\.8 | |
| 2 or More | 35\.2 | |
\*Persons of Hispanic origin may be of any race; all other racial/ethnic groups are non-Hispanic. AI/AN = American Indian / Alaskan Native
\*\*Note: Estimates for the Native Hawaiian / Other Pacific Islander group are not reported in the above figure due to low precision of data collection in 2022.
## Mental Health Treatment — AMI
- Figure 2 presents data on mental health treatment received within the past year by U.S. adults aged 18 or older with any mental illness (AMI). NSDUH defines mental health treatment as having received inpatient treatment/counseling or outpatient treatment/counseling, or having used prescription medication to help with mental health.
- In 2022, among the 59.3 million adults with AMI, 30.0 million (50.6%) received mental health treatment in the past year.
- More females with AMI (56.9%) received mental health treatment than males with AMI (41.6%).
- The percentage of young adults aged 18-25 years with AMI who received mental health treatment (49.1%) was slightly lower than adults with AMI aged 26-49 years (50.0%) and aged 50 and older (52.7%).
#### Figure 2
Mental Health Treatment Received in Past Year Among U.S. Adults with Any Mental Illness (2022)
Bar chart with 11 bars.
Data Courtesy of SAMHSA
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying Percent. Range: 0 to 60.
End of interactive chart.
| Demographic | Percent | |
|---|---|---|
| Overall | 50\.6 | |
| Sex | Female | 56\.9 |
| Male | 41\.6 | |
| Age | 18-25 | 49\.1 |
| 26-49 | 50\.0 | |
| 50+ | 52\.7 | |
| Race and Ethnicity | Hispanic or Latino\* | 39\.6 |
| White | 56\.1 | |
| Black or African American | 37\.9 | |
| Two or More Races | 56\.0 | |
| Asian | 36\.1 | |
\*Persons of Hispanic origin may be of any race; all other racial/ethnic groups are non-Hispanic. Note: Estimates for the Native Hawaiian / Other Pacific Islander group is not reported in the above figure due to low precision of data collection in 2022.
## Prevalence of Serious Mental Illness (SMI)
- Figure 3 shows the past year prevalence of SMI among U.S. adults.
- In 2022, there were an estimated 15.4 million adults aged 18 or older in the United States with SMI. This number represented 6.0% of all U.S. adults.
- The observed prevalence of SMI was higher among females (7.1%) than males (4.8%).
- Young adults aged 18-25 years had the highest prevalence of SMI (11.6%) compared to adults aged 26-49 years (7.6%) and aged 50 and older (3.0%).
- The prevalence of SMI was highest among adults reporting two or more races (11.8%), followed by American Indian / Alaskan Native (AI/AN) adults (7.3%). The prevalence of SMI was lowest among Native Hawaiian / Other Pacific Islander (NH/OPI) adults (3.5%).
#### Figure 3
Past Year Prevalence of Serious Mental Illness Among U.S. Adults (2022)
Bar chart with 13 bars.
Data Courtesy of SAMHSA
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying Percent. Range: 0 to 16.
End of interactive chart.
| Demographic | Percent | |
|---|---|---|
| Overall | 5\.5 | |
| Sex | Female | 7\.0 |
| Male | 4\.0 | |
| Age | 18-25 | 11\.4 |
| 26-49 | 7\.1 | |
| 50+ | 2\.5 | |
| Race and Ethnicity | Hispanic or Latino\* | 5\.1 |
| White | 6\.1 | |
| Black or African American | 4\.3 | |
| Asian | 2\.8 | |
| NH/OPI | 6\.3 | |
| AI/AN | 9\.3 | |
| 2 or More | 8\.2 | |
\* Persons of Hispanic origin may be of any race; all other racial/ethnic groups are non-Hispanic. NH/OPI = Native Hawaiian / Other Pacific Islander \| AI/AN = American Indian / Alaskan Native.
## Mental Health Treatment — SMI
- Figure 4 presents data on mental health treatment received within the past year by U.S. adults 18 or older with serious mental illness (SMI). The NSDUH defines mental health treatment as having received inpatient treatment/counseling or outpatient treatment/counseling or having used prescription medication to help with mental health.
- In 2022, among the 15.4 million adults with SMI, 10.2 million (66.7%) received mental health treatment in the past year.
- More females with SMI (71.4%) received mental health treatment than males with SMI (59.3%).
- The percentage of young adults aged 18-25 years with SMI who received mental health treatment (61.4%) was lower than adults with SMI aged 26-49 years (67.4%) and aged 50 and older (71.0%).
#### Figure 4
Mental Health Treatment Received in Past Year Among U.S. Adults with Serious Mental Illness (2022)
Bar chart with 10 bars.
Data Courtesy of SAMHSA
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying Percent. Range: 0 to 80.
End of interactive chart.
| Demographic | Percent | |
|---|---|---|
| Overall | 65\.4 | |
| Sex | Female | 67\.6 |
| Male | 61\.3 | |
| Age | 18-25 | 57\.9 |
| 26-49 | 67\.0 | |
| 50+ | 71\.0 | |
| Race and Ethnicity | Hispanic or Latino\* | 58\.6 |
| White | 68\.6 | |
| Black or African American | 62\.3 | |
| Two or More Races | 68\.6 | |
\*Persons of Hispanic origin may be of any race; all other racial/ethnic groups are non-Hispanic. Note: Estimates for Asian, Native Hawaiian / Other Pacific Islander, and American Indian / Alaskan Native groups are not reported in the above figure due to low precision.
## Prevalence of Any Mental Disorder Among Adolescents
- Based on diagnostic interview data from National Comorbidity Survey Adolescent Supplement (NCS-A), Figure 5 shows lifetime prevalence of any mental disorder among U.S. adolescents aged 13-18.1
- An estimated 49.5% of adolescents had any mental disorder.
- Of adolescents with any mental disorder, an estimated 22.2% had severe impairment and/or distress. DSM-IV based criteria were used to determine severity level.
#### Figure 5
Lifetime Prevalence of Any Mental Disorder Among Adolescents (2001-2004)
Bar chart with 7 bars.
Data from the National Comorbidity Survey Adolescent Supplement (NCS-A)
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying Percent. Range: 0 to 60.
End of interactive chart.
| Demographic | Percent | |
|---|---|---|
| Overall | 49\.5 | |
| With Severe Impairment | 22\.2 | |
| Sex | Female | 51\.0 |
| Male | 48\.1 | |
| Age | 13-14 | 45\.3 |
| 15-16 | 49\.3 | |
| 17-18 | 56\.7 | |
## Data Sources
1. Merikangas KR, He JP, Burstein M, Swanson SA, Avenevoli S, Cui L, Benjet C, Georgiades K, Swendsen J. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A). *J Am Acad Child Adolesc Psychiatry.* 2010 Oct;49(10):980-9. [PMID: 20855043](http://www.ncbi.nlm.nih.gov/pubmed/20855043/)
2. Substance Abuse and Mental Health Services Administration. (2023). Key substance use and mental health indicators in the United States: Results from the 2022 National Survey on Drug Use and Health (HHS Publication No. PEP23-07-01-006, NSDUH Series H-58). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from <https://www.samhsa.gov/data/report/2022-nsduh-annual-national-report>.
### Statistical Methods and Measurement Caveats
#### National Survey on Drug Use and Health (NSDUH)
Diagnostic Assessment:
- The NSDUH AMI and SMI estimates were generated from a prediction model created from clinical interview data collected on a subset of adult NSDUH respondents (4,912 total respondents between 2008 and 2012) who completed an adapted (past 12 month) version of the Structured Clinical Interview for DSM-IV-TR Axis I Disorders (Research Version, Non-patient Edition) (SCID-I/NP; First, Spitzer, Gibbon, & Williams, 2002), and was differentiated by level of functional impairment based on the Global Assessment of Functioning Scale (GAF; Endicott, Spitzer, Fleiss, & Cohen, 1976).
- The assessment included diagnostic modules assessing the patients for the signs of: mood disorders (e.g., major depressive episode, manic episode), anxiety disorders (e.g., panic disorder, generalized anxiety disorder, posttraumatic stress disorder), eating disorders (e.g., anorexia nervosa), impulse control disorders (e.g. intermittent explosive disorder, and adjustment disorder), and a psychotic symptoms screen.
- The assessment did not contain diagnostic modules assessing the following: adult attention deficit hyperactivity disorder (ADHD), autism spectrum disorders, schizophrenia or other psychotic disorders (although the assessment included a psychotic symptom screen).
- People who only have disorders that are not included in these diagnostic modules may not be adequately detected. However, there are known patterns of high comorbidities among mental disorders; these patterns increase the likelihood that people who meet AMI and/or SMI criteria were detected by the study, as they may also have one or more of the disorders assessed in the SCID-I/NP.
Population:
- The entirety of NSDUH respondents for the AMI and SMI estimates were the civilian, non-institutionalized population aged 18 years old or older residing within the United States.
- The survey covered residents of households (persons living in houses/townhouses, apartments, condominiums; civilians living in housing on military bases, etc.) and persons in non-institutional group quarters (e.g., shelters, rooming/boarding houses, college dormitories, migratory workers' camps, and halfway houses).
- The survey did not cover persons who, for the entire year, had no fixed address (e.g., persons experiencing homelessness and/or transient persons not in shelters); were on active military duty; or who resided in institutional group quarters (e.g., correctional facilities and long-term hospitals).
- Some people in these excluded categories had AMI and/or SMI, but were not accounted for in the NSDUH AMI and/or SMI estimates.
- Data regarding sex of the respondent was assessed using male and female categories only.
Survey Non-response:
- In 2022, 52.0% of the selected NSDUH sample of people 18 or older did not complete the interview. This rate of non-response is higher than in years before 2020. Please see the Background on the 2022 NSDUH and the COVID-19 Pandemic section below for more information.
- Reasons for non-response to interviewing include the following: refusal to participate (29.3%); respondent unavailable or never at home (18.2%); and other reasons such as physical/mental incompetence or language barriers (4.5%).
- People with mental illness may disproportionately fall into these non-response categories. While NSDUH weighting includes non-response adjustments to reduce bias, these adjustments may not fully account for differential non-response by mental illness status.
Data Suppression:
- For some groups, data are not reported due to low precision. Data may be suppressed in the above charts if the data do not meet acceptable ranges for prevalence estimates, standard error estimates, and sample size.
Background on the 2022 NSDUH and the COVID-19 Pandemic:
- Data collection methods for the 2022 NSDUH changed in several ways because of the COVID-19 pandemic: the 2022 NSDUH continued the use of multimode data collection procedures (both in-person and virtual data collection) that were first implemented in the fourth quarter of the 2020 NSDUH. Overall, 40.7% of interviews were completed via the web, and 59.3% were completed in person. In 2022, the weighted response rates for household screening and for interviewing were 25.5% and 47.4%, respectively, for an overall response rate of 12.1% for people aged 12 or older.
- Given the use of multimode data collection procedures throughout the entirety of the collection year and the rate of non-response, comparison of estimates from the 2022 NSDUH with those from prior years must be made with caution.
Please see the [2022 National Survey on Drug Use and Health Methodological Summary and Definitions report](https://www.samhsa.gov/data/report/2022-methodological-summary-and-definitions) for further information on how these data were collected and calculated.
#### National Comorbidity Survey Adolescent Supplement (NCS-A)
Diagnostic Assessment and Population:
- The NCS-A was carried out under a cooperative agreement sponsored by NIMH to meet a request from Congress to provide national data on the prevalence and correlates of mental disorders among U.S. youth. The NCS-A was a nationally representative, face-to-face survey of 10,123 adolescents aged 13 to 18 years in the continental United States. The survey was based on a dual-frame design that included 904 adolescent residents of the households that participated in the adult U.S. National Comorbidity Survey Replication and 9,244 adolescent students selected from a nationally representative sample of 320 schools. The survey was fielded between February 2001 and January 2004. DSM-IV mental disorders were assessed using a modified version of the fully structured World Health Organization Composite International Diagnostic Interview.
Survey Non-response:
- The overall adolescent non-response rate was 24.4%. This is made up of non-response rates of 14.1% in the household sample, 18.2% in the un-blinded school sample, and 77.7% in the blinded school sample. Non-response was largely due to refusal (21.3%), which in the household and un-blinded school samples came largely from parents rather than adolescents (72.3% and 81.0%, respectively). The refusals in the blinded school sample, in comparison, came almost entirely (98.1%) from parents failing to return the signed consent postcard.
For more information, see [PMID: 19507169](https://www.ncbi.nlm.nih.gov/pubmed/19507169) and the [NIMH NCS-A study page](https://www.nimh.nih.gov/news/science-updates/2010/national-survey-confirms-that-youth-are-disproportionately-affected-by-mental-disorders).
Last Updated: September 2024 |
| Shard | 129 (laksa) |
| Root Hash | 7295144728021232729 |
| Unparsed URL | gov,nih!nimh,www,/health/statistics/mental-illness s443 |